Bradley Radoff and Jumana Capital filed a Schedule 13D disclosing a combined 7.6% stake in Genesco and issued a letter demanding board representation. The filing identifies the group as actively seeking to influence corporate governance at the Nashville-based footwear and apparel retailer, which operates 1,425 stores across the Journeys, Schuh, and Johnston & Murphy brands. Genesco shares traded up 4.8% in the session following disclosure, closing at $28.14 on volume 2.3x the thirty-day average.
The activist letter, issued concurrently with the 13D, criticizes capital allocation decisions and board composition without specifying initial director nominees. Radoff, a former activist at Ancora Advisors, brings experience from prior campaigns at Kaman Corporation and Griffon Corporation. Jumana Capital, a newer entrant in the activist space, has participated in two disclosed campaigns since founding in 2022. The coalition's 7.6% position represents roughly 1.1 million shares at current trading prices, a stake valued near $31 million. Neither party disclosed acquisition timing, but the 13D filing window suggests accumulation occurred within the past ten days.
Genesco has underperformed the S&P Retail Select Index by 18 percentage points over the trailing two years, with comparable-store sales declining in five of the past six quarters. The company carries $142 million in net debt and generated $87 million in free cash flow over the last twelve months, a margin compressed by inventory normalization following pandemic-era overstocking. Management's decision to maintain $40 million in annual dividends while store productivity declined has drawn scrutiny from sell-side analysts, three of whom downgraded the stock in the past four months. The activists' focus on board composition suggests dissatisfaction with oversight of these capital decisions rather than immediate operational intervention.
Allocators should monitor two specific events. First, Genesco's next earnings call, scheduled for late March, will clarify whether management engages constructively or signals entrenchment. Second, the company's annual meeting, typically held in late June, represents the natural inflection point for a proxy contest if settlement discussions fail. The activists have not yet filed preliminary proxy materials, but the 13D's language—"believes the Company would benefit from new perspectives"—typically precedes formal nomination within thirty to forty-five days. Institutional holders control 89% of shares outstanding, with Vanguard, BlackRock, and Dimensional holding 31% combined, a concentrated ownership base that often accelerates settlement timelines.
The filing arrives as retail activism shifts toward mid-cap names with clean balance sheets and depressed multiples. Genesco trades at 0.31x trailing sales, a 40% discount to its five-year average, despite maintaining positive free cash flow and no near-term debt maturities. The proxy season calendar suggests resolution by early May if both sides move efficiently.